⌘K

Home/Filings/4/0000875320-25-000122

4//SEC Filing

Ambrose Kristen 4

Accession 0000875320-25-000122

CIK 0000875320other

View on SEC.gov Company Profile

Filed

Feb 27, 7:00 PM ET

Accepted

Feb 28, 4:24 PM ET

Size

4.5 KB

Accession

0000875320-25-000122

Insider Transaction Report

Form 4

Period: 2025-02-26

VERTEX PHARMACEUTICALS INC / MAVRTX

Ambrose Kristen

SVP & Chief Accounting Officer

Transactions

Tax Payment
Common Stock
2025-02-26$479.61/sh−1,241$595,196→ 7,845 total

Documents

1 file

4
wk-form4_1740777887.xmlPrimary
FORM 4

Issuer

VERTEX PHARMACEUTICALS INC / MA

CIK 0000875320

Entity typeother

Related Parties

1

filerCIK 0001856587

Filing Metadata

Form type: 4
Filed: Feb 27, 7:00 PM ET
Accepted: Feb 28, 4:24 PM ET
Size: 4.5 KB

View on SEC.gov